Mr Hurd was eager to hear about the new technology behind Omnigen and patients who would benefit from receiving the treatment. Our Sales and Marketing Director, Kate Pym, explained that Omnigen originates from mothers who wanted to donate their amniotic tissue after birth.
The technicians at NuVision transform this tissue into a biological bandage that helps heal eyes afflicted with corneal diseases. Omnigen has been shipped to clinics all over the UK and Europe to patients who are at risk of losing their vision.
Mr Hurd and his team said they were compelled by the story of Omnigen and felt excited about the expansion of Omnigen use in hospitals around the UK.
Kate and Mr Hurd discussed the regulatory storage hurdles that NuVision is trying to overcome before he offered the company his best wishes and continued his tour around MediCity.
To find out more about NuVision, please click here.